Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
-
J Rheum Dis. 2014 Apr;21(2):64-73. Korean. Multicenter Study. https://doi.org/10.4078/jrd.2014.21.2.64
Won S , Sung YK , Cho SK , Choi CB , Koh EM , Kim SK , Kim J , Kim TH , Kim HA , Nah SS , Bang SY , Suh CH , Shim SC , Yoo DH , Yoon BY , Lee SH , Lee SW , Lee SS , Lee YA , Lee J , Lee J , Lee HS , Lim MK , Jun JB , Jeon CH , Jung YO , Chung WT , Cha HS , Choe JY , Hong SJ , Bae SC .
Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, Korea. scbae@hanyang.ac.kr
Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
Department of Rheumatology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.
Department of Rheumatology, Catholic University of Daegu, School of Medicine, Daegu, Korea.
Department of Rheumatology, Jeju National University Hospital, Jeju, Korea.
Department of Rheumatology, Ajou University Hospital, Suwon, Korea.
Department of Rheumatology, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Department of Rheumatology, Hanyang University Guri Hospital, Guri, Korea.
Department of Rheumatology, Chungnam National University Hospital, Daejeon, Korea.
Department of Rheumatology, Inje University Ilsan Paik Hospital, Goyang, Korea.
Department of Rheumatology, Kyung Hee University Hospital at Gangdong, Seoul, Korea.
Department of Rheumatology, Dong-A University Hospital, Busan, Korea.
Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea.
Department of Rheumatology, Kyung Hee University Hospital, Seoul, Korea.
Department of Rheumatology, Ewha Womans University Mokdong Hospital, Seoul, Korea.
Department of Rheumatology, Eulji University Hospital, Daejeon, Korea.
Department of Rheumatology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
Department of Rheumatology, Hallym University College of Medicine, Seoul, Korea.
Abstract

OBJECTIVE: The purpose of this study is to examine the difference between the numbers of patients in rheumatoid arthritis (RA) who are eligible to TNF inhibitors by the past Korean National Health Insurance reimbursement guideline and by the disease activity score with 28-joint assessment (DAS28) based criteria. METHODS: Data were obtained from a multi-center registry for biologics users in Korean RA patients, BIOlogics Pharmacoepidemiologic StudY (BIOPSY). DAS28 was calculated based on either ESR or CRP, and DAS28 of more than 5.1 or between 3.2 and 5.1 with radiographic changes was defined as a cut-off point for the initiation of TNF inhibitors. For the maintenance criteria, we used both of improving in DAS28 score (>1.2) and low disease activity (DAS 28<3.2). Differences between the numbers in each step by two criteria were described with Chi-square test and Kappa agreement. RESULTS: Of the 489 patients in BIOPSY, 299 were included in this study. Among them, 278 patients (93.0%) were eligible of TNF inhibitors when we applied the new initiation criteria with DAS28-ESR, and 244 patients (81.6%) were indicated for TNF inhibitors with DAS28-CRP. For the maintenance criteria, a low disease activity (DAS28<3.2) in 3 months after starting TNF inhibitors is too strict for achieving (33.6% with DAS28-ESR and 50.0% with DAS28-CRP). Instead, decreasing DAS28 by more than 1.2 is more reasonable as a tool for deciding early responsiveness of TNF inhibitors in RA patients (81.2% both with DAS28-ESR and DAS28-CRP). CONCLUSION: Our results show that the candidates for TNF inhibitors will be enormously changed according to a change in the reimbursement criteria. To define appropriate patients to receive TNF inhibitors, a further study with regard to the impact of changes in the reimbursement criteria on the outcomes of RA patients will be required.

Copyright © 2019. Korean Association of Medical Journal Editors.